跳到主要內容

臺灣博碩士論文加值系統

(3.236.124.56) 您好!臺灣時間:2021/08/02 07:55
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

我願授權國圖
: 
twitterline
研究生:徐之昇
研究生(外文):Hsu Chih Sheng
論文名稱:策略聯盟與企業績效關係:美國製藥產業之實證研究
論文名稱(外文):The Relationship between Strategic Alliance and Business Performance: An Empirical Study of American Pharmaceutical Industry
指導教授:林博文林博文引用關係
指導教授(外文):Bou-Wen Lin
學位類別:碩士
校院名稱:國立清華大學
系所名稱:科技管理研究所
學門:商業及管理學門
學類:其他商業及管理學類
論文種類:學術論文
論文出版年:2004
畢業學年度:92
語文別:中文
論文頁數:58
中文關鍵詞:製藥產業策略聯盟創新能力企業績效
外文關鍵詞:pharmaceutical industrystrategic allianceinnovationbusiness performance
相關次數:
  • 被引用被引用:5
  • 點閱點閱:155
  • 評分評分:
  • 下載下載:0
  • 收藏至我的研究室書目清單書目收藏:4
本篇論文主要探討製藥產業不同的企業特性對企業績效的影響,探討企業規模、企業經費投入密度、無形資產數目以及外部資源等對企業績效關係之影響。透過整合資料庫的迴歸分析,本研究發現並獲得以下結論:一、藥廠的營運效率績效主要來自於員工人數的多寡,而藥廠資金愈雄厚並不會幫助營運效率的提升,反而有時會有反效果的情形發生。二、藥廠之研發投資密度大小對於企業的創新產出效率有顯著的正向關聯性存在,而管銷經費投資的比例愈高時,則會有較高的市場價值。三、當藥廠的專利數愈多時,代表企業的無形資產愈多,而企業的績效也相對會較好。四、藥廠之過去聯盟經驗總數量與企業績效間無明顯的關係存在;不過,進一步依照新藥研發之不同階段將研發策略聯盟數量區分為發現階段、臨床前試驗階段、人體臨床試驗階段三項階段之策略聯盟數量來做進一步分析研究時,企業之前期產品聯盟(數量)與企業的績效表現雖然較無顯著關係,但企業愈後期產品聯盟(數量)與企業之聯盟績效有正向且顯著的關係,意即後期階段產品的聯盟比早期階段產品聯盟有更好的企業績效表現。五、藥廠研發投入密度與臨床前試驗階段聯盟數量和人體臨床試驗階段聯盟數量卻有相當大程度的交互作用關係,尤以愈後期的人體臨床試驗階段聯盟數量交互作用更大,意即他們之間有互依的關係存在,也因此,研發投入密度與愈後期階段聯盟數量對於在本研究所探討之應變數的干擾效果愈大。
Strategic alliance is one of the most important strategies for firms in the pharmaceutical industry to gain access to valuable technological resources. The purpose of this study is to investigate how the characteristics and strategic alliances of American pharmaceutical firms influence their business performance. Data were gathered from three sources: Recap’s Biotech Alliance, USPTO and Compustat. The methods used in the research include descriptive statistics, correlation analysis, regression analysis and general linear model analysis of the SPSS software. Results show that the number of firm’s employee is positively associated with its financial performance, while a firm’s total assets can endanger its profitability. Besides, the R&D investment density is positively associated with its innovation performance, the management and market investment density is positively associated with its market value as well. In addition, the more the number of firm’s patent, the better the business performance. Furthermore, there are no conspicuous relationship between strategic alliance experiences of a firm and their business performance, but the later phase research strategic alliances (like pre-clinical and clinical phase) would contribute to its innovation performance, financial performance and the cumulative market value. Finally, there are interactive effects between the R&D investment densities the later phase research strategic alliances.
中文文獻

1. 財團法人生物技術開發中心 (民90),「2001製藥產業年鑑」
2. 湯珮妤 (民89),「企業類型與研發之初、專利權成效遞延效果研究」,
國立中正大學會計研究所碩士論文

英文文獻

1. Aaker, D.A. (1992), “Developing Business Strategies”, 3 ed., New York: John
Wiley & Sons.
2. Aboody, D. and Lev, B. (2001), “R&D Production in The Chemical Industry,”
Working paper, New York University.
3. Achilladelis, B., Schwarzkopf, A. and Cines, M. (1987), “A Study of Innovation in
the Pesticide Industry: Analysis of the Innovation Record of an Industrial Sector,”
Research Policy, 16(2-4), pp.175-212.
4. Ahuja, G. and Katila, A. (2001), “Technological Acquisitions and the Innovation
Performance of Acquiring Firms: A Longitudinal Study,” Strategy Management
Journal, 22(3), pp.197-220.
5. Anand, B. and T. Khanna (2000), “Do Firms Learn to Create Value? The Case of
Alliances,” Strategic Management Journal, 21, pp.295-316.
6. Balakrishnan, S. and Wernerfelt, B. (1986), “Technical Change Competition and
Vertical Integration”, Strategic Management Journal, 7, pp.347-359.
7. Barney, J. B. (1997), “Gaining and Sustaining Competitive Advantage,” New York:
Addition-Wesley Publishing Company.
8. Baum, J. A. C., Calabrese, T. and Silverman, B. S. (2000), “Don’t Go it Alone:
Alliance Network Composition and Startups’ Performance in Canadian
Biotechnology,” Strategic Management Journal, 21, pp.267-294.
9. Borys. and Jemison, D.B. (1989), “Hybrid Arrangements as Strategic Alliances:
Theoretical Issues in Organizational Combinations”, Academy of Management
Review, 14(2), pp.234-249.
10. Brenner, M.S. and Ruchton, B. M. (1989), “Sales Growth and R&D in the
Chemical Industry”, Research Technology Management, 32, pp.8-15.
11. Burrill, G. S.and Biotech (2001), The Biotechnology Industry Annual Report,
Burrill & Company
12. Calazo (1993), “Face to Face/ Strategic Alliances Keep Customers Plugged in”,
Management Review
13. Carolis, D. M. and Deeds, D. L. (1999), “The Impact of Stocks and Flows of
Organizational Knowledge on Firm Performance: An Empirical Investigation of
the Biotechnology Industry,” Strategic Management Journal, 20, pp.953-968.
14. Chakrabarti, A. K. and Weisenfeld, U. (1991), “An Empirical Analysis of
Innovation Strategies of Biotechnology Firms in The US”, Journal of Engineering
and Technology Management, 8, pp.137-164.
15. Chen, H., Hu, M. and Shieh, J.(1991),“The Effect of International Joint
Ventures: Thecase of U.S. investment in China,” Journal of Banking and
Finance, 24, pp.1747-1765.
16. Chung, K. H. and Pruitt, S. W. (1994), “A Simple Approximation of Tobin’s q,”
Financial Management, 23, pp.70-74.
17. Contractor, F.J. and Lorange, P. (1998), “Why Should Firm Cooperate?The
Strategy and Economics Basis For Cooperative Ventures,” Cooperative
Strategies in International Business, Lexingion Books.
18. David, B A. and Maryann, P. F. (2003), “Technology Analysis & Strategic
Management.” Abingdon: 15(2), pp.273.
19. Davlin, G. and Bleackley, M. (1988), “Strategies Alliances-Guidelines for
Success”, Long Range Planning, 21(5), pp.18-23.
20. Drucker, P. F. (1993), “Managing in Tmrbulent Times”, Harper & Row, New York,
Reprint edition.
21. Eerden, C. and Saelens, F. H. (1991), “The Use of Science and Technology
Indicators in Strategic Planning,” Long Range Planning, 24(3), pp.18-25.
22. Erica, W. and Jane, B. D. (1994), “A Shift to External Alliances for Product
Development in The Pharmaceutical Industry” R&D Management, 24(3),
pp.249-260.
23. Evans, H., Ashworth, G., Chellew, M., Davidson, A. and Tower, D. (1996),
“Exploiting Activity-Based Information: Easy as ABC,” Management Accounting,
74, Jul-Aug., pp.24-29.
24. Franco, L. G. (1989), “Global Corporate Competition: Who’s Winning, Who’s
Losing, and the R&D Factor as One Reason Why”, Strategic Management
Journal, 10, pp.449-474.
25. Frank, T. R. (2001), “Complementary Assets, Strategic Alliances, and The
Incumbent’s Advantage: An Empirical Study of Industry and Firm Effects in The
Biopharmaceutical Industry” Research Policy, 30, pp.1235-1251.
26. Ghertman, M. & Obadia, J. (1992), “Balance of Complementary Assets and
Stability Conditions of a Dynamic Transaction Theory of Alliances: The Cost of
US Biotechnology”, Working Paper, Chamber de Commerce et D’industrie de
Paris.
27. Glaister, K. M. and Buckley, P. J. (1996), “Strategic motives for international
alliance formation”, Journal of Management Studies, 33(3), pp.301-302.
28. Grabowski, H. and Mueller, D. (1978), “Industrial Research and Development,
Intangible Capital Stocks, and Firm Profit Rates,” Bell Journal of Economics,
9, pp328-343.
29. Graves, S. B. and Langowitz, N. S. (1993), “Innovative Productivity and Returns
to Scale in the Pharmaceutical Industry,” Strategic Management Journal, 14,
pp.593-605.
30. Griliches, Z. (1981), “Market Value, R&D, and Patents,” Economic Letters,
7(2), pp.183-187.
31. Griliches, Z. (1989), “Patents: Recent Trends and Puzzles,” Brookings Pap. Econ.
Act. Microeconomics, pp.3291-3330.
32. Griliches, Z. (1990), “Patent Statistics as Economic Indicators: A Survey”, Journal of Economic Literature, 28, December, pp.1661-1707.
33. Gupta, A. and Misra, L.(2000), “The Value of Experiential Learning by
Organizations: Evidence From International Joint Ventures,” Journal of Financial
Research, 23, pp.77-102.
34. Harrigan, K. R. (1987), “Strategic Alliance: Their New Role in Global
Competition”, Columbia Journal of World Business, 22(2), pp.67-69.
35. Higgins, J. M. (1995), “The Core Competence: Innovation,” Planning Review,
23(6), pp.32-35.
36. Hill, C. and Deeds, D. (1996), “The Importance of Industry Structure for the
Determination of Firm Profitability: A Neo-Austrian Perspective,” Journal of
Management Studies, 33(4), pp.429-451.
37. Hitt, M. A., Hoskisson, R. E., Johnson, R. A., and Moesel, D. D. (1996), “The
Market for Corporate Control and Firm Innovation,” Academy of Management
Journal, 39(5), pp.1084-1119.
38. Hirschey, M. (1982), “Intangible Capital Aspects of Advertising and R&D
Expenditures,” The journal of Industrial Economics, 30, pp.375-390.
39. Hirschey, M., and Weyandt, J. (1985), “Amortization Policy for Advertising and
Research and Development Expenditures,” Journal of Accounting Research, 23,
pp.326-335.
40. Holt, K. (1988), “The Role of User in Product Innovation,” Technovation, 12(5),
pp.53-56.
41. Hula, G. (1989), “Intangible Capital, Market Share and Corporate Strategy,”
Applied Economics, l21, pp.1535-1547.
42. Jensen, E. J. (1987), “Research Expenditures and the Discovery of New Drugs,”
Journal of Industrial Economics, 36, pp.83-95.
43. Joel, A. C., Baum, Tony, C. and Brian S. S. (2000), “Don’t Go It Alone: Alliance
Network Composition and Startups’ Performance in Canadian Biotechnology”
Strategic Management Journal, 21, pp.267-294.
44. John, H. and Schakenrad, O. (1994), “The Effect of Strategic Technology
Alliances on Company Performance”, Strategic Management Journal, 15,
pp.291-309.
45. Jung, J. (2000), “Creating Value Through Innovation.” IBM Institute for Business
Value, December 2000
46. Killing, J. P. (1988),”Understanding Alliances: The Role of Task and
Organizational Complexity”, Cooperative Strategies in International Business, in
F.J. Contractor and P.Lorange, Mass. Toronto: D.C. Health & Co. Lexington.
47. Kogut, B. and Singh, H. (1985), “Entering the United States by Acquisition or
Joint Venture: Country Patterns and Cultural Characteristics”, Working Paper,
Jones Center, The Wharton School, Univ. of Penn.
48. Krubasik, E. and Lautenschlager, H. (1993), “Forming Successful Strategic
Alliance in High-Tech Business, Chapter 4 of Joel Blecke and David Ernst (eds.),
Collaborating to Compete-using Strategic Alliance and Acquisitions in the Global
Marketplace”, New York: Wiley, pp.53-65.
49. Levitt, B. and March, J. G. (1988), “Organizational Learning,” Annual Review of
Sociology, 14, pp.319-340.
50. Lewis, J. D. (1990), “Partnerships for profit”, N.Y.: The Free Press.
51. Lindenberg, E. B. and Ross, S. A. (1981), “Tobin’s q Ratio and Industrial
Organization,” Journal of Business, (Jan), pp.1-32.
52. Lorange, P. and Roos, J. (1992), “Strategic Alliance: Formation Implementation
and Evolution”, Massachusetts: Blackwell.
53. Lynch, R. P. (1989), “The Pratical Guide to Joint Venture and Corporate
Alliance”, New York: John Wiley & Son.
54. Mason, J. C. (1993), “Strategic alliances: Partnering for success”, Management
Review, pp.320-325.
55. Miller, D. (1982), “ The Correlated of Entrepreneurship in Three Types of Firm”,
Management Science, 29, Jan, pp.770-791.
56. Mohr, J. and Spekman, R. (1994), “Characteristics of Partnership Success:
Partnership Attributes, Communication Behavior, and Conflict Resolution
Techniques”, Strategic Management Journal, 15, pp.135-152.
57. Monck, C. S., Porter, R. P., Quintas, P., Storey, D. J., and Wynarczyk, P. (1988),
“Science Parks and the Growth of High Technology Firms.” London: Croom
Helm.
58. Murray, J. E. and J. F. Mahon (1993), “Strategic Alliance: Gateway to the New
Europ,” Long Range Planning, 26(4), pp.102-111.
59. Nordhaus, W. (1969), “An Economics Theory of Technological Changes.” Amer.
Econ. Rev., 59(2), pp.18-28.
60. Nueno, P. and Oosterveld, J. (1988), “Management Technological Alliances”,
Long Range Planning, 21(3), pp.11-17.
61. Pakes, A. and Griliches, Z. (1984), “Patents and R&D at the Firm Level: A First
Look.”, J. Polit. Econ., pp.55-72.
62. Pakes, A. (1985), “On Patents, R&D and The Stock Market Rate of Returm.”, J.
Polit. Econ., 93(2), pp.390-409.
63. Parkhe, A. (1991), “Interfirm Diversity, Organization Learning and Longevity in
Global Strategic Alliance”, Journal of International Business Studies, Fourth
Quaeter, pp.579-601.
64. Pekar, J. P. and Allio, R. (1994), “Making Alliances Work—Guidelines for
Success”, Long Range Planning, 27(4), pp.54.65.
65. Perlmutter, H. V. and Heenan, D. A. (1986), “Cooperate to Compete Globally”,
Harvard Business Review, Mar./Apr., pp.136-152.
66. Porter, M. E. and Fuller, M. B. (1986), “Coalitions and Global Strategy”, in M.E.
Porter(ed.),Competitive in Global Industries, Boston, MA: Harvard Business
School Press, pp.315-343.
67. Quinn, R. E. and Rohrbaugh, J. (1983), “A Spatial Model of Effectiveness
Criteria: Towards A Competing Values Approach to Organizational Analysis”, Management Science, 29(3), March, pp.363-377.
68. Richard, M. and Steers (1975), “Problems in the Measurement of Organizational
Effectiveness”, Administrative Science Quarterly, 20, pp.546-558.
69. Root, F. R. (1988), “Some Taxonomies of International Cooperative
Arrangement”, in F.J. Contractor and P. Lorange, Cooperative Strategic in
International Business, Mass./Toronto: D.C. Heath & Co./Lexington.
70. Rothwell, R. (1986), “Public Innovation Policy: To Have or to Have not ?” R&D
Management, 16(1), pp.25-37.
71. Scherer, F. M. (1985)., “Firm Size, Market Structure, Opportunity, and The Output
of Patented Inventions”, American Economic Review, 55, pp.27-34.
72. Schmookler, J. (1996), “Invention and Economics Growth.”, Cambridges: Harvard
U. Press, MA.
73. Schumpeter, J.A. (1934)., “The Theory of Economic Development”, Cambridges:
Harvard University Press, MA.
74. Sierra, M.C. (1995), “Managing Global Alliances—Key Steps for Successful
Collaboration”, Addison-Wesley Publishing Company.
75. Souder and Nassar (1990), “Choosing and R&D Consortium”, Research
Technology Management, pp.36-41.
76. Sougiannis, T. (1994), “The Accounting Based Valuation of Corporate R&D,” The
Accounting Review, 69(1), pp.44-68.
77. Takac, P. F. and Singh, C. P. (1992), “Strategic in Banking”, Management
Decision, 30 (1), pp.32-43.
78. Tobin, J. and Brainard, W. (1968), “Pitfalls in Financial Model Building,”
American Economic Review, 59, pp.99-102.
79. Venkatraman, N. and Vasudevan, R. (1986), “Measurement of Business
Performance in Strategy Research: A Comparison of Approaches”, Academy of
Management Review, 11, pp.801-814.
80. Walter, W. P., Kenneth, W. K. and Laurel, S. D. (1996), “Interorganizational
Collaboration and The Locus of Innovation: Networks of Learning in
Biotechnology” Administrative Science Quarterly, 41, pp.116-145.
81. Willard, G. and Woo, C.Y. (1983), “Performance Representation in Business
Police Research: Discussion and Recommendation”, Paper Presented at The 43rd
Annual National Meetings of The Academy of Management, Dallas.
82. Williamson, O. E. (1975), “Markets and Hierachies: Analysis and Antitrust
Implications”, New York: Free Press.
83. Yoshino, M. Y. and Srinivasa, R. U. (1995), “Strategic Alliances-An
Entrepreneurial Approach to Globalization”, Boston.: Harvard Business
School Press, MA.
84. Yuan-Chieh Chang (2003), “Benefits of Co-operation on Innovative Performance:
Evidence from Integrated Circuits and Biotechnology Firms in The UK and
Taiwan” R&D Management, 33(4), pp.425-437.
85. Zuckerman, H. S. and Aunno, T. A. (1990), “Hospital Alliances: Cooperative
Strategy in a Competitive Environment”, Health Care Management Review,15(2),
pp.21-30.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top